NEW DEVELOPMENTS IN THE MANAGEMENT OF CONGENITAL FACTOR XIII DEFICIENCY [CORRIGENDUM]


Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma

As the most common type of renal cell carcinoma (RCC), the renal clear cell carcinoma (ccRCC) is highly malignant Extension Cords and insensitive to chemotherapy or radiotherapy.Although systemic immunotherapies have been successfully applied to ccRCC in recent years, screening for patients who can benefit most from these therapies is still essenti

read more

Peer review of the pesticide risk assessment for the active substance cyflumetofen in light of confirmatory data submitted

Abstract RECT DRM Counter TBL Set(3/CN) The conclusions of EFSA following the peer review of the initial risk assessment carried out by the competent authority of the rapporteur Member State, the Netherlands, for the pesticide active substance cyflumetofen are reported.The context of the peer review was that requested by the European Commission fol

read more